SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-08-001018
Filing Date
2008-08-29
Accepted
2008-08-29 13:44:06
Documents
10
Period of Report
2008-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 6-K lorus6k.htm 6-K 19077
2 ANNUAL FINANCIAL STATEMENTS ex991.htm EX-99.1 1116556
3 MANAGEMENT DISCUSSION AND ANALYSIS ex992.htm EX-99.2 361338
4 ANNUAL INFORMATION FORM ex993.htm EX-99.3 574826
5 CEO/CFO CERTIFICATIONS ex994.htm EX-99.4 26766
6 LETTER TO SHAREHOLDERS ex995.htm EX-99.5 15611
7 LORUS LOGO lorus.jpg GRAPHIC 15928
8 CLINICAL DEVELOPMENT CHART clinical_development.jpg GRAPHIC 132335
9 KPMG LOGO kpmg.jpg GRAPHIC 5144
10 GRAPHIC sig2.jpg GRAPHIC 5295
  Complete submission text file 0001279569-08-001018.txt   2335139
Mailing Address 2 MERIDIAN ROAD TORONTO A6 M9W 4Z7
Business Address 2 MERIDIAN ROAD . TORONTO A6 M9W 4Z7
LORUS THERAPEUTICS INC (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0531
Type: 6-K | Act: 34 | File No.: 001-32001 | Film No.: 081048376
SIC: 2836 Biological Products, (No Diagnostic Substances)